Atrium Innovations Inc. — Investor Relations & Filings
Filings indexed
66
across all filing types
Latest filing
2014-03-06
Regulatory Filings
Country
CA
Canada
Listing
TSX
ATB
Atrium Innovations Inc. is a globally recognized leader in the development, manufacturing, and commercialization of innovative, science-based natural health products. The company's portfolio primarily consists of nutritional and dietary supplements, including specialized products, vitamins, and minerals, alongside certain cosmetic and chemical formulations. Atrium focuses on delivering professionally endorsed solutions that support a holistic approach to individualized health and healing. A key component of its operations includes providing educational resources, such as expert-led webinars, focused on advancing knowledge in natural medicine and nutrition science for healthcare practitioners.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Other securityholders documents - English.pdf | 2014-03-06 | English | |
| Other securityholders documents - English.pdf | 2014-02-14 | English | |
| Material change report - French.pdf | 2014-02-14 | English | |
| Other.pdf | 2013-12-10 | English | |
| Other.pdf | 2013-12-10 | English | |
| Material change report - French.pdf | 2013-12-10 | English |
Browse filings by year
10 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2014
3 filings
| |||||
| 47171854 | Other securityholders documents - English.pdf | 2014-03-06 | English | ||
| 47171858 | Other securityholders documents - English.pdf | 2014-02-14 | English | ||
| 47171862 | Material change report - French.pdf | 2014-02-14 | English | ||
|
2013
7 filings
| |||||
| 47171882 | Other.pdf | 2013-12-10 | English | ||
| 47171893 | Other.pdf | 2013-12-10 | English | ||
| 47171897 | Material change report - French.pdf | 2013-12-10 | English | ||
| 47171919 | Material change report - English.pdf | 2013-10-23 | English | ||
| 47171926 | Other.pdf | 2013-10-18 | English | ||
| 47171948 | Material change report - English.pdf | 2013-10-18 | English | ||
| 47171952 | Annual information form - English.pdf | 2013-03-29 | English | ||
|
2012
2 filings
| |||||
| 47171959 | Annual information form - English.pdf | 2012-03-31 | English | ||
| 47171984 | Other.pdf | 2012-03-31 | English | ||
|
2011
3 filings
| |||||
| 47171990 | Material change report - French.pdf | 2011-10-11 | English | ||
| 47172250 | Other.pdf | 2011-09-29 | English | ||
| 47172252 | Material change report - English.pdf | 2011-08-18 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Ajanta Pharma Ltd.
Specialty pharmaceutical firm focused on complex generics a…
|
AJANTPHARM | IN | Manufacturing |
|
Akari Therapeutics Plc
Develops next-gen antibody-drug conjugates using proprietar…
|
AKTX | US | Manufacturing |
|
Akebia Therapeutics, Inc.
A biopharmaceutical company that develops and commercialize…
|
AKBA | US | Manufacturing |
|
Akeso, Inc.
Global commercial-stage biopharma developing innovative ant…
|
9926 | KY | Manufacturing |
|
Aktis Oncology, Inc.
A clinical-stage biotech developing targeted alpha radiopha…
|
AKTS | US | Manufacturing |
|
Akums Drugs and Pharmaceuticals Limited
CDMO providing end-to-end pharmaceutical manufacturing and …
|
AKUMS | IN | Manufacturing |
|
Albert David Ltd.
Produces pharmaceutical formulations, infusions, and specia…
|
ALBERTDAVD | IN | Manufacturing |
|
Aldeyra Therapeutics, Inc.
Develops medications for immune-mediated ocular and systemi…
|
ALDX | US | Manufacturing |
|
Aleafia Health Inc.
Vertically integrated cannabis company with cultivation, pr…
|
AH | CA | Manufacturing |
|
Alector, Inc.
Clinical-stage biotech using immuno-neurology to treat neur…
|
ALEC | US | Manufacturing |
Atrium Innovations Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/45568/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=45568 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=45568 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=45568 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 45568}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Atrium Innovations Inc. (id: 45568)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.